References
- American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003;26:S103–5
- Metzger BE, Lowe LP, Dyer AR, et al. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002
- Harlev A, Wiznitzer A. New insights on glucose pathophysiology in gestational diabetes and insulin resistance. Curr Diab Rep 2010;10:242–7
- Stefan N, Häring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol 2013;9:144–52
- Hill KE, Wu S, Motley AK, et al. Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis. J Biol Chem 2012;287:40414–24
- Misu H, Takamura T, Takayama H, et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 2010;12:483–95
- Yang SJ, Hwang SY, Choi HY, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 2011;96:E1325–9
- Zhang Y, Chen X. Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation. Am J Physiol Endocrinol Metab 2011;300:E77–85
- Choi HY, Hwang SY, Lee CH, et al. Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic fatty liver disease. Diabetes Metab J 2013;37:63–71
- Roman M, Lapolla A, Jitaru P, et al. Plasma selenoproteins concentrations in type 2 diabetes mellitus – a pilot study. Transl Res 2010;156:242–50
- Retnakaran R, Austin PC, Shah BR. Effect of subsequent pregnancies on the risk of developing diabetes following a first pregnancy complicated by gestational diabetes: a population-based study. Diabet Med 2011;28:287–92
- Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903–16
- Coate KC, Smith MS, Shiota M, et al. Hepatic glucose metabolism in late pregnancy: normal versus high-fat and -fructose diet. Diabetes 2013;62:753–61
- Farhan S, Handisurya A, Todoric J, et al. Fetuin-A characteristics during and after pregnancy: result from a case control pilot study. Int J Endocrinol 2012;2012:896736
- Stein S, Stepan H, Kratzsch J, et al. Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism 2010;59:33–7
- Koyama H, Abdulah R, Ohkubo T, et al. Depressed serum selenoprotein P: possible new predicator of increased risk for cerebrovascular events. Nutr Res 2009;29:94–9
- Huang K, Liu H, Chen Z, Xu H. Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Atherosclerosis 2002;162:137–44
- Stranges S, Tabák AG, Guallar E, et al. Selenium status and blood lipids: the cardiovascular risk in Young Finns study. J Intern Med 2011;270:469–77
- Misu H, Ishikura K, Kurita S, et al. Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PLoS One 2012;7:e34952
- Combs GF Jr, Watts JC, Jackson MI, et al. Determinants of selenium status in healthy adults. Nutr J 2011;10:75